Low Doses of Anti-VEGF Therapy Effective in Infants with ROP
According to results from the CARE-ROP study, Low doses of anti-VEGF therapy with ranibizumab are effective in infants with retinopathy of prematurity (ROP). The study findings were published in the JAMA Pediatrics